Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy
Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravit...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Fan, Nai-Wen [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases - Chowdhury, I. ELSEVIER, 2015, JCMA, Hong Kong [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:77 ; year:2014 ; number:2 ; pages:101-107 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jcma.2013.10.012 |
|---|
| Katalog-ID: |
ELV039288471 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV039288471 | ||
| 003 | DE-627 | ||
| 005 | 20230624060008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcma.2013.10.012 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014007000019.pica |
| 035 | |a (DE-627)ELV039288471 | ||
| 035 | |a (ELSEVIER)S1726-4901(13)00280-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Fan, Nai-Wen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| 264 | 1 | |c 2014 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. | ||
| 650 | 7 | |a intravitreal bevacizumab |2 Elsevier | |
| 650 | 7 | |a photodynamic therapy |2 Elsevier | |
| 650 | 7 | |a polypoidal choroidal vasculopathy |2 Elsevier | |
| 650 | 7 | |a combination therapy |2 Elsevier | |
| 650 | 7 | |a reduced-fluence photodynamic therapy |2 Elsevier | |
| 700 | 1 | |a Lau, Ling-Ing |4 oth | |
| 700 | 1 | |a Chen, Shih-Jen |4 oth | |
| 700 | 1 | |a Yang, Chang-Sue |4 oth | |
| 700 | 1 | |a Lee, Fenq-Lih |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Chowdhury, I. ELSEVIER |t Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases |d 2015 |d JCMA |g Hong Kong [u.a.] |w (DE-627)ELV012997633 |
| 773 | 1 | 8 | |g volume:77 |g year:2014 |g number:2 |g pages:101-107 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jcma.2013.10.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 77 |j 2014 |e 2 |h 101-107 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
n w f nwf |
|---|---|
| matchkey_str |
fannaiwenlaulingingchenshihjenyangchangs:2014----:oprsnfhefcordcdlecpooyaiteayihnrvteleaiuaadtnadlecao |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.40 |
| publishDate |
2014 |
| allfields |
10.1016/j.jcma.2013.10.012 doi GBVA2014007000019.pica (DE-627)ELV039288471 (ELSEVIER)S1726-4901(13)00280-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Fan, Nai-Wen verfasserin aut Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Elsevier Lau, Ling-Ing oth Chen, Shih-Jen oth Yang, Chang-Sue oth Lee, Fenq-Lih oth Enthalten in Elsevier Chowdhury, I. ELSEVIER Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases 2015 JCMA Hong Kong [u.a.] (DE-627)ELV012997633 volume:77 year:2014 number:2 pages:101-107 extent:7 https://doi.org/10.1016/j.jcma.2013.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 77 2014 2 101-107 7 045F 610 |
| spelling |
10.1016/j.jcma.2013.10.012 doi GBVA2014007000019.pica (DE-627)ELV039288471 (ELSEVIER)S1726-4901(13)00280-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Fan, Nai-Wen verfasserin aut Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Elsevier Lau, Ling-Ing oth Chen, Shih-Jen oth Yang, Chang-Sue oth Lee, Fenq-Lih oth Enthalten in Elsevier Chowdhury, I. ELSEVIER Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases 2015 JCMA Hong Kong [u.a.] (DE-627)ELV012997633 volume:77 year:2014 number:2 pages:101-107 extent:7 https://doi.org/10.1016/j.jcma.2013.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 77 2014 2 101-107 7 045F 610 |
| allfields_unstemmed |
10.1016/j.jcma.2013.10.012 doi GBVA2014007000019.pica (DE-627)ELV039288471 (ELSEVIER)S1726-4901(13)00280-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Fan, Nai-Wen verfasserin aut Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Elsevier Lau, Ling-Ing oth Chen, Shih-Jen oth Yang, Chang-Sue oth Lee, Fenq-Lih oth Enthalten in Elsevier Chowdhury, I. ELSEVIER Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases 2015 JCMA Hong Kong [u.a.] (DE-627)ELV012997633 volume:77 year:2014 number:2 pages:101-107 extent:7 https://doi.org/10.1016/j.jcma.2013.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 77 2014 2 101-107 7 045F 610 |
| allfieldsGer |
10.1016/j.jcma.2013.10.012 doi GBVA2014007000019.pica (DE-627)ELV039288471 (ELSEVIER)S1726-4901(13)00280-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Fan, Nai-Wen verfasserin aut Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Elsevier Lau, Ling-Ing oth Chen, Shih-Jen oth Yang, Chang-Sue oth Lee, Fenq-Lih oth Enthalten in Elsevier Chowdhury, I. ELSEVIER Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases 2015 JCMA Hong Kong [u.a.] (DE-627)ELV012997633 volume:77 year:2014 number:2 pages:101-107 extent:7 https://doi.org/10.1016/j.jcma.2013.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 77 2014 2 101-107 7 045F 610 |
| allfieldsSound |
10.1016/j.jcma.2013.10.012 doi GBVA2014007000019.pica (DE-627)ELV039288471 (ELSEVIER)S1726-4901(13)00280-3 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Fan, Nai-Wen verfasserin aut Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy 2014 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Elsevier Lau, Ling-Ing oth Chen, Shih-Jen oth Yang, Chang-Sue oth Lee, Fenq-Lih oth Enthalten in Elsevier Chowdhury, I. ELSEVIER Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases 2015 JCMA Hong Kong [u.a.] (DE-627)ELV012997633 volume:77 year:2014 number:2 pages:101-107 extent:7 https://doi.org/10.1016/j.jcma.2013.10.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 77 2014 2 101-107 7 045F 610 |
| language |
English |
| source |
Enthalten in Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases Hong Kong [u.a.] volume:77 year:2014 number:2 pages:101-107 extent:7 |
| sourceStr |
Enthalten in Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases Hong Kong [u.a.] volume:77 year:2014 number:2 pages:101-107 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| topic_facet |
intravitreal bevacizumab photodynamic therapy polypoidal choroidal vasculopathy combination therapy reduced-fluence photodynamic therapy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases |
| authorswithroles_txt_mv |
Fan, Nai-Wen @@aut@@ Lau, Ling-Ing @@oth@@ Chen, Shih-Jen @@oth@@ Yang, Chang-Sue @@oth@@ Lee, Fenq-Lih @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012997633 |
| dewey-sort |
3610 |
| id |
ELV039288471 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039288471</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624060008.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcma.2013.10.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014007000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039288471</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1726-4901(13)00280-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fan, Nai-Wen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">intravitreal bevacizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">photodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">polypoidal choroidal vasculopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">combination therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">reduced-fluence photodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lau, Ling-Ing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Shih-Jen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Chang-Sue</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Fenq-Lih</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Chowdhury, I. ELSEVIER</subfield><subfield code="t">Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases</subfield><subfield code="d">2015</subfield><subfield code="d">JCMA</subfield><subfield code="g">Hong Kong [u.a.]</subfield><subfield code="w">(DE-627)ELV012997633</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:77</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:101-107</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcma.2013.10.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">77</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="h">101-107</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Fan, Nai-Wen |
| spellingShingle |
Fan, Nai-Wen ddc 610 bkl 44.40 Elsevier intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| authorStr |
Fan, Nai-Wen |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012997633 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.40 bkl Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy Elsevier |
| topic |
ddc 610 bkl 44.40 Elsevier intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy |
| topic_unstemmed |
ddc 610 bkl 44.40 Elsevier intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy |
| topic_browse |
ddc 610 bkl 44.40 Elsevier intravitreal bevacizumab Elsevier photodynamic therapy Elsevier polypoidal choroidal vasculopathy Elsevier combination therapy Elsevier reduced-fluence photodynamic therapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l i l lil s j c sjc c s y csy f l l fll |
| hierarchy_parent_title |
Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases |
| hierarchy_parent_id |
ELV012997633 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012997633 |
| title |
Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| ctrlnum |
(DE-627)ELV039288471 (ELSEVIER)S1726-4901(13)00280-3 |
| title_full |
Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| author_sort |
Fan, Nai-Wen |
| journal |
Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases |
| journalStr |
Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
101 |
| author_browse |
Fan, Nai-Wen |
| container_volume |
77 |
| physical |
7 |
| class |
610 610 DE-600 610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Fan, Nai-Wen |
| doi_str_mv |
10.1016/j.jcma.2013.10.012 |
| dewey-full |
610 |
| title_sort |
comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| title_auth |
Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| abstract |
Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. |
| abstractGer |
Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. |
| abstract_unstemmed |
Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA |
| container_issue |
2 |
| title_short |
Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy |
| url |
https://doi.org/10.1016/j.jcma.2013.10.012 |
| remote_bool |
true |
| author2 |
Lau, Ling-Ing Chen, Shih-Jen Yang, Chang-Sue Lee, Fenq-Lih |
| author2Str |
Lau, Ling-Ing Chen, Shih-Jen Yang, Chang-Sue Lee, Fenq-Lih |
| ppnlink |
ELV012997633 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.jcma.2013.10.012 |
| up_date |
2024-07-06T20:15:11.641Z |
| _version_ |
1803862054421921792 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039288471</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624060008.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcma.2013.10.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014007000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039288471</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1726-4901(13)00280-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fan, Nai-Wen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Photodynamic therapy (PDT) has previously been reported to be effective in treating polypoidal choroidal vasculopathy (PCV), with satisfactory polyp regression. However, the optimum treatment protocol remains controversial. This study compared the effect of reduced-fluence PDT combined with intravitreal bevacizumab (rPDT/IVB) and standard-fluence PDT (sPDT) alone for treating symptomatic PCV in Chinese patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">intravitreal bevacizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">photodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">polypoidal choroidal vasculopathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">combination therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">reduced-fluence photodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lau, Ling-Ing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Shih-Jen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Chang-Sue</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Fenq-Lih</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Chowdhury, I. ELSEVIER</subfield><subfield code="t">Novel Prognostic Scores for Survival and Intracranial Failure in Patients Treated With Radiosurgery Alone to Melanoma Brain Metastases</subfield><subfield code="d">2015</subfield><subfield code="d">JCMA</subfield><subfield code="g">Hong Kong [u.a.]</subfield><subfield code="w">(DE-627)ELV012997633</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:77</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:101-107</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcma.2013.10.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">77</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="h">101-107</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3993206 |